Video Credit: Reuters Studio - Duration: 01:28s - Published
Novavax appears effective against UK variant
Novavax says its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the UK, according to a preliminary analysis.
In this video, we dive deep into the Human Metapneumovirus (HMPV) – a respiratory virus that has been causing concern worldwide, particularly following recent outbreaks in China. We’ll explore what HMPV is, how it spreads, its symptoms, and how it compares to other viruses like COVID-19 and the flu. Despite the lack of a vaccine, learn about preventive measures and why health experts are keeping a close watch on the virus. Stay informed about the latest developments and how countries, including India, are preparing for potential outbreaks.
#HMPV #HumanMetapneumovirus #RespiratoryVirus #GlobalHealth #VirusSpread #HMPVOutbreak #HealthAlert #FluSeason #PandemicWatch #RespiratoryInfections #PublicHealth
~HT.318~PR.274~ED.102~
Health Secretary Wes Streeting and NHS chief executive Amanda Pritchard visit the headquarters of the London Ambulance Service. Mr Streeting insists the government has “hit the ground running” since taking office and “prepared the best we can for this winter” while acknowledging the challenges with flu, Covid and norovirus. Report by Blairm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.